反応式
[CH3:1][N:2]1[CH2:7][CH2:6][CH:5]([C:8]([OH:10])=O)[CH2:4][CH2:3]1.CCN=C=NCCCN(C)C.C(N(CC)CC)C.[NH2:29][CH2:30][CH2:31][C:32]1[CH:37]=[CH:36][C:35]([O:38][C:39](=[O:48])[N:40]([CH3:47])[C:41]2[CH:46]=[CH:45][CH:44]=[CH:43][CH:42]=2)=[CH:34][CH:33]=1.C(O)(C(F)(F)F)=O>C(Cl)Cl>[CH3:1][N:2]1[CH2:3][CH2:4][CH:5]([C:8]([NH:29][CH2:30][CH2:31][C:32]2[CH:33]=[CH:34][C:35]([O:38][C:39](=[O:48])[N:40]([CH3:47])[C:41]3[CH:42]=[CH:43][CH:44]=[CH:45][CH:46]=3)=[CH:36][CH:37]=2)=[O:10])[CH2:6][CH2:7]1参加物
7
反応物 5
生成物 1
試薬・触媒・溶媒 1
実験手順
A solution of 1-methylpiperidine-4-carboxylic acid (0.3 mmol), EDAC (0.36 mmol) and triethylamine (1.0 mmol) in CH2Cl2 (10 mL) was added N-hydroxybenzoetriazole and N-methyl-N-phenyl-carbamic acid 4-(2-amino-ethyl)phenyl ester as its TFA salt (0.3 mmol). The mixture was stirred 16 h at rt and purified by preparative HPLC (Gilson) to give the title compound in 5% yield as an oil.
後処理
- custompurified by preparative HPLC (Gilson)
出典と根拠
- ORDレコード
- ord-e658490ac2be4e628ef14c182c669eb1
- 出典データセット
- uspto-grants-2006_06
- 特許番号
- US07067517B2
関連ノート
読み込み中…